Evidence map›Paper›PMID 31999308›Full record

ArticleJAMA otolaryngology-- head & neck surgery2020

Development of a Sleep Apnea-Specific Health State Utility Algorithm.

Jonathan R Skirko, Kathryn T James, Louis P Garrison, Edward M Weaver

Registry-linked trialAbstract read
In one paragraph

Article in JAMA otolaryngology-- head & neck surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07132307 (Reducing Obstructive Sleep Apnea After Hypoglossal Nerve Stimulation Through), which is not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07132307 narecruitingnot on this mapstarted 2025, after this paper: background citation

Reducing Obstructive Sleep Apnea After Hypoglossal Nerve Stimulation Through

TypeinterventionalSponsorWashington University School of MedicineRan2025 to 2027Enrolled30ConditionsObstructive Sleep ApneaArmsMandibular advancement device (MAD)
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jonathan R SkirkoDivision of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of Utah, Salt Lake City.
Kathryn T JamesComparative Effectiveness, Cost and Outcomes Research Center, University of Washington, Seattle.
Louis P GarrisonPharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle.
Edward M WeaverDepartment of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle.

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Nasal Turbinate Reduction & CPAP Outcomes for Sleep Apnea: A Sham-Controlled RCTR01HL084139 · NHLBI · UNIVERSITY OF WASHINGTON · PI WEAVER, EDWARD M · 2007 to 2011
$3.0M
Nasal Obstruction and Sleep Apnea Treatment OutcomesK23HL068849 · NHLBI · UNIVERSITY OF WASHINGTON · PI WEAVER, EDWARD M · 2003 to 2007
$764k
NCATS NIH HHS UL1 TR002319NHLBI NIH HHS K23 HL068849NHLBI NIH HHS R01 HL084139
6 · The paper itself

Abstract

Importance: With the increasing emphasis on economic evaluations, there is a need for additional methods of measuring patient utility in the obstructive sleep apnea population. Objective: To develop and validate a utility scoring algorithm for a sleep apnea-specific quality-of-life instrument. Design, Setting, and Participants: Development and validation were conducted at 2 tertiary referral sleep centers and associated sleep clinics and included patients with newly diagnosed obstructive sleep apnea from a randomized clinical trial and an associated observational cohort study. Baseline participants were randomly divided into a model development group (60%) and a cross-validation group (40%). Main Outcomes and Measures: Utility scoring of the Symptoms of Nocturnal Obstruction and Related Events (SNORE-25) was mapped from the SF-6D utility index through multiple linear regression in the development sample using the Akaike information criterion to determine the best model. Results: A total of 500 participants (development, n = 300; validation, n = 200) were enrolled; the analyzed sample of 500 participants included 295 men (59%), and the mean (SD) age was 48.6 (12.8) years, with a range of 18 to 90 years. The mean (SD) SF-6D utility among participants with untreated sleep apnea was 0.61 (0.08; range, 0.40-0.85) with similar utility across sleep apnea severity groups. The best-fit model (the SNORE Utility Index) was the natural log conversion of the instrument subscales (r2 = 0.32 in the development sample). The SNORE Utility Index retained this association within the validation sample (r2 = 0.33). Conclusions and Relevance: The SNORE Utility Index provides a validated, disease-specific, preference-weighted utility instrument that can be used in future studies of patients with obstructive sleep apnea.

Indexed as

AlgorithmsQuality of LifeAdolescentAdultAgedAged, 80 and overContinuous Positive Airway PressureFemaleHumansMaleMiddle AgedPolysomnographyReproducibility of ResultsSleep Apnea, ObstructiveSymptom AssessmentYoung Adult

Identifiers

PMID31999308
PMCPMC7042933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.